GRI

GRI Bio, Inc. GRI

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.1M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$164.7K total
HRT FINANCIAL LP
$50.0KNew
VANGUARD CAPITAL MANAGEMENT LLC
$37.8KNew
GEODE CAPITAL MANAGEMENT, LLC
$24.5K-24.8%
CITADEL ADVISORS LLC
$23.7KNew
MORGAN STANLEY
$15.5KNew
UBS Group AG
$8.7K-43.6%
Tower Research Capital LLC (TRC)
$4.3K+129.6%
BARCLAYS PLC
$147New
BlackRock, Inc.
$120.0%
Caitong International Asset Management Co., Ltd
$4New
DANSKE BANK A/S
$40.0%
See all 11 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/GRI

Earnings Per Share

13fpro.ai/company/GRI

Loading ratio trend…

GRI key financials by period

Reported revenue, net income and operating margin by fiscal year, from GRI Bio, Inc.'s annual filings on SEC EDGAR.

GRI Bio, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2020$100.0K$-4.8M—
Source: GRI filings on SEC EDGAR →

About GRI Bio, Inc. (GRI): stock profile, AI score and financials

GRI Bio, Inc. (GRI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GRI is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.1m in revenue and is scored on the micro-cap board instead. Top institutional holders of GRI by reported 13-F value include HRT FINANCIAL, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. GRI trades on the Nasdaq exchange and files with the SEC under CIK 1824293. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GRI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GRI Bio, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1824293 →